News

press

Sep 16, 2021

Press Release

Shasqi Presents Initial Data Validating Approach of Click Chemistry Activated Oncology Therapeutics at ESMO Congress 2021

conference

Aug 29, 2021

2021 - ESMO - Clinical Poster

Early pharmacokinetic data from a Phase I study of SQ3370 (NCT04106492) in patients with advanced solid tumors provides proof-of-concept for the click chemistry-based CAPAC platform

conference

Aug 29, 2021

2021 - ESMO - Preclinical Poster

Click Activated Protodrugs Against Cancer (CAPAC) Platform Enhances the Safety, Pharmacokinetics, and Antitumor Efficacy of Cancer Therapies in vivo

press

Apr 27, 2021

Press Release

Shasqi Awarded Prestigious Direct-to-Phase-2 Small Business Innovation Research Grant by National Cancer Institute

press

Apr 10, 2021

Press Release

Shasqi to Present Data on Novel Click Chemistry Platform at the American Association for Cancer Research (AACR) Annual Meeting

conference

Mar 25, 2021

2021 - AACR - Clinical Poster

First-in-human Phase I Study of SQ3370, a Click Activated Protodrug Therapy, in Patients with Advanced Solid Tumors

conference

Mar 25, 2021

2021 - AACR - Preclinical Poster

The CAPAC Platform Maximizes Therapeutic Benefit and Reduces Systemic Cytotoxic Exposure in Small and Large Animals

press

Feb 10, 2021

Press Release

Shasqi Announces Strategic Advisors as it Advances Click-Chemistry based Treatments for Cancer

press

Jan 27, 2021

Press Release

Shasqi Announces Publication of Preclinical Data Demonstrating Proof-of-Principle for Click-Activated Approach to Cancer Treatment

publication

Jan 20, 2021

Advanced Therapeutics

SQ3370 Activates Cytotoxic Drug via Click Chemistry at Tumor and Elicits Sustained Responses in Injected & Non-injected Lesions

conference

Jan 13, 2021

2021 - JPMHC Presentation

Shasqi's Click Activated Against Protodrugs

press

Jan 7, 2021

Press Release

Shasqi to Present at 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021